Loading data for GLMD — first visit, this takes a few seconds.
Galmed Pharmaceuticals Ltd. (GLMD)
NasdaqCM: GLMD
· 即時價格 · USD
3.92
-0.20 (-4.85%)
收盤價： Sep 02, 2026, 8:00 PM
3.92
-4.83%
盤後: 6:41 PM
股價、關鍵數字和最新消息，都在這一頁。
Galmed Pharmaceuticals Ltd.（GLMD）股價、分析與資料
無可用資料
| 買價 | 3.06 |
| 市值 | 4.29M |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -11.1M |
| 0.68 | |
| -16.48 | |
| n/a | |
| -4 | |
| P/B (ttm) | 0.24 |
| P/S (ttm) | 0.00 |
| 財報日期 | n/a |
| 賣價 | 5.37 |
| 成交量 | 23,997 |
| 20 日平均成交量 | 100,984 |
| 開盤價 | 4.09 |
| 前收盤價 | 4.12 |
| 當日區間 | 3.82 - 4.12 |
| 52 週範圍 | 3.29 - 13.20 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 GLMD
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The comp...
完整的公司簡介財報驚奇
Galmed Pharmaceuticals 已於 Jul 8, 2026 公布季度財報：
- 營收為 $0 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -2.32 超出預期 0.72, 年增 53.23% 成長.
9 月前 · Associated Press Finance
BC-Most Active StocksHIVE Digital Technologies Ltd. 30,450,329 3.7899